The overall procedural technical success rate, researchers reported, was 96.8%.

The model sits at approximately 1.5 cm long and offers researchers a new way to observe the heart in motion.

The mortality rate was 17% for patients undergoing SAVR following a failed TAVR. 

CMS has proposed expanding its national coverage policy for transcatheter edge-to-edge repair of the mitral valve so that it includes patients with functional mitral regurgitation. 

The artificial valve would give clinicians a new option that lasts up to 25 years and does not require prescribing anticoagulation medications.

Low-risk transcatheter atortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery.

Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).

Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.

Infective endocarditis is a relatively rare complication of TAVR, but the infection can be fatal when it does strike.

Do patients in the United States have sufficient access to TAVR centers?

A new study at the University of Cincinnati aims to find out why some TAVR patients experience clotting issues that can lead to substantial side effects.

The use of conscious sedation during transcatheter aortic valve replacement is associated with better patient outcomes, including a decrease in mortality, than general anesthesia.